Coverage
-
March 04, 2013
Pennsylvania has reached a nearly $2 million deal with Healthpoint Ltd. and DFB Pharmaceuticals Inc. to settle allegations that Healthpoint submitted false reimbursement claims to Medicaid for its unapproved skin ulcer ointment Xenaderm, state Attorney General Kathleen G. Kane announced Monday.
11 other articles on this case.
View all »